Skip to main content
MSC-ALV • RESEARCH USE ONLY

Alveolar Type 2 Cells

Cells that produce surfactant and support lung epithelium repair. Responsible for surfactant production and differentiation toward alveolar type 1 cells.

Product image for a stem cell product from Akira Biotech
Surfactant · compliance
AT2 FUNCTION
— Produces surfactant lipoproteins that lower alveolar surface tension, keeping units open and stabilizing ventilation mechanics.
AT2 → AT1 plasticity
EPITHELIAL REPAIR
— Can transition toward type 1 pneumocytes to restore gas-exchange surface after injury, inflammation, or fibrotic stress.
Less inflammation · less fibrosis
LUNG MICROENVIRONMENT
— Designed to temper pulmonary inflammation and fibrosis while contributing innate immune defense via antimicrobial effectors.
ROUTES, FORMATS & APPLICATIONS
Routes
IVIntravenous
Quantities
10 Million Cells2ml
25 Million Cells5ml
Potential Applications

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pulmonary Fibrosis
  • Acute Respiratory Distress Syndrome (ARDS)
  • Cystic Fibrosis
  • Asthma
  • Post-COVID Lung Damage

Compliance · Stem cells

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup